Natus Medical

About:

Natus provides healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments.

Website: http://www.natus.com

Top Investors: ROTH Capital Partners

Description:

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Natus products include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Total Funding Amount:

$30.8M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

San Carlos, California, United States

Founded Date:

1987-01-01

Contact Email:

info.europe(AT)natus.com

Founders:

William Moore

Number of Employees:

1001-5000

Last Funding Date:

2006-08-24

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai